Company news

Benitec Biopharma Inc. news in 2024

Benitec Biopharma Inc.'s news releases, calls and decks from 2024, newest first.

View company

Benitec Biopharma to Participate in Upcoming Investor Conferences in December

November 25, 2024

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

November 13, 2024

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

November 3, 2024

Benitec Biopharma Announces Updated Investor Webcast Information

October 13, 2024

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

October 11, 2024

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update

September 25, 2024

Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society

September 17, 2024

Benitec Biopharma CEO to Participate in OPMD Awareness Day Webinar

September 16, 2024

Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study

July 14, 2024

Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors

June 30, 2024

Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update

May 12, 2024

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference

April 30, 2024

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

April 17, 2024

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

April 17, 2024

Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024

April 8, 2024

Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update

February 12, 2024

Decks in 2024